Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases
NCT07134153
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
139
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
T-DXd
Sponsor
Fudan University